Protalix BioTherapeutics (PLX)
Protalix BioTherapeutics Key Statistics
Pro Data ExportCurrent Valuation
Dividends and Shares
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Dividend Date | |
| Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin | 64.59% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
| Profit Margin | -158.4% |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 2.812 |
| Debt to Equity Ratio | |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -11.65% |
| Year to Date Stock Returns | 24.54% |
| 1 Year Stock Returns | -0.97% |
| 3 Year Stock Returns | 61.58% |
| 52 Week High | 7.70 |
| 52 Week Low | 4.06 |
Income Statement
| Revenues TTM | 0.696M |
| Revenue Per Share TTM | 0.0077 |
| Revenue Growth | -37.87% |
| Gross Profit TTM | -1.371M |
| EBITDA TTM Pro | Go Pro |
| Income from Cont. Ops Pro | Go Pro |
| Net Income TTM | -37.38M |
| Earnings Per Share TTM | -0.44 |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | -4.07M |
| Cash Financing TTM | 25.56M |
| Cash Operations TTM | -25.86M |
| Capital Expenditures | 0.81M |
Share Statistics
| Shares Outstanding | 90.82M |
Balance Sheet
| Cash and ST Investments | 45.60M |
| Total Assets | 68.46M |
| Liabilities | 74.92M |
| Book Value | -6.457M |
| Book Value per Share | -0.0711 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
| Long Term Debt | 0.00 |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
PLX News
Protalix BioTherapeutics to Present at Three Upcoming Healthcare Conferences
May 29, 7:30AM GlobeNewswire
May 29, 7:30AM GlobeNewswire
@groberjg07 $ARNA $PLX immediately opened on FDA approval and yet we are still halted..
about 21 days ago by BiopharmaPro
about 21 days ago by BiopharmaPro
$PLX http://stks.co/3lrN recovery after the Approval profit taking, will be volatile till the option expiry 5/19
about 21 days ago by gantosj
about 21 days ago by gantosj
Protalix BioTherapeutics to Present at Three Upcoming Healthcare Conferences
May 10, 7:30AM GlobeNewswire
May 10, 7:30AM GlobeNewswire
$PLX pumper article won't save this thing. massive insider selling tells the story. this wont go above 7.5 imo
about 23 days ago by johnkelly
about 23 days ago by johnkelly
well apparantly $PLX insiders dont think it'll go over $7.50 anytime soon! never seen so much selling lol http://stks.co/3iSq
about 23 days ago by johnkelly
about 23 days ago by johnkelly
$VTUS Phase 3 data for anal fissures, expected by May 15th, 120M market share, no competitor, grossly undervalued $JAZZ $PLX $VVUS $$
about 24 days ago by peterumble
about 24 days ago by peterumble
RT @peterumble Short stocks: $EXEL $RGEN $PLX $POZN $CVM , markets hate uncertainty $SPY- SPY down 3.1% POZN up 0.8% since Wed. close. DD.
about 26 days ago by Glopolon
about 26 days ago by Glopolon
$PLX glad i held on..this is going LOW on monday. ceo has NO shares now..dont blame them, i would have done the same
about 27 days ago by gotgame83
about 27 days ago by gotgame83
$PLX why do people think the pfe is going to buy them out? dont they already have a partnership with them? any benefit for pfe?
about 27 days ago by gotgame83
about 27 days ago by gotgame83
$PLX last minute buying ahed of "weekend buyout" comical...
about 27 days ago by johnkelly
about 27 days ago by johnkelly
Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); U.S. Tali Approval May Unlock Potential
Apr 19, 9:14AM Street Insider
Apr 19, 9:14AM Street Insider
Protalix BioTherapeutics Sets Record Date for Annual Meeting of Shareholders
Mar 16, 4:01PM GlobeNewswire
Mar 16, 4:01PM GlobeNewswire
Auriga Reiterate a 'Buy' on Protalix BioTherapeutics (PLX); No Material Changes in 10-K
Mar 01, 10:42AM Street Insider
Mar 01, 10:42AM Street Insider
Protalix BioTherapeutics to Participate at Two Upcoming Global Healthcare Conferences
Feb 23, 7:30AM GlobeNewswire
Feb 23, 7:30AM GlobeNewswire
Protalix BioTherapeutics Announces Closing of Public Offering and Exercise of Over-Allotment Option
Feb 22, 4:15PM GlobeNewswire
Feb 22, 4:15PM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PLX | 6.14 | -0.21 | -3.31% | 576.71M |
| SONC | 8.28 | +0.01 | +0.12% | 500.75M |
| SON | 30.48 | -0.33 | -1.07% | 3.098B |
| SOMX | 0.30 | +0.01 | +3.45% | 13.95M |
| SOMH | 8.50 | +0.00 | +0.00% | 45.39M |
| SOL | 1.24 | -0.02 | -1.59% | 109.43M |
| SOHU | 43.02 | -1.75 | -3.91% | 1.705B |
| SOFO | 7.200 | -0.00 | -0.00% | 27.72M |
| SNSS | 2.90 | -0.11 | -3.65% | 140.93M |
| SNPS | 29.12 | -0.43 | -1.46% | 4.308B |
